Bavaria Medizin Technologie GmbH engages in design, development, and manufacture of different types of catheters and delivery devices for vascular and non-vascular applications. It offers catheters for coronary, peripheral and cranial indications, dilatation catheters, devices for local drug delivery, stent delivery devices, and ear, nose and throat devices. The company was founded by Hanson S. Gifford, III in 1992 and is headquartered in Wessling, Germany.

Sutra Medical, Inc. is an American private company that designs and develops trans catheter solutions.

CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).

Jacobson Resonance Enterprises, Inc is a bio-tech and bio-medical enterprise.\nThe company develops resonance and electro-magnetic equipment, processes and applications.\nThese applications are use of resonance technology in the medical, veterinary medicine, food, agricultural, recreational, pharmaceutical, and environmental industries are currently being pursued.\nThe company was founded in 1988 and is headquartered in Boynton Beach, FL.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Cardious, Inc. manufactured and distributed medical devices. It provided aortic valve bypass graft system as a minimally invasive and beating heart. The company was founded by Kem Schankereli, James L. Pokorney and Patrick McCarthy in 2010 and was headquartered in Northfield, MN.

Mitral Technologies SA provides research and development services for medical devices and cardiovascular diseases. The company was founded by Luigi Tozzi, Jean-Paul Rasschaert and Piergiorgio Tozzi on December 8, 2017 and is headquartered in Liege, Belgium.

Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure.\nCurrently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR.\nTheir goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention.

Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China.

Albany International Corp. is a global advanced textiles and materials processing company.

devie medical GmbH engages in the development, production, and distribution of drug-eluting heart valve. The company was founded in 2018 and is headquartered in Jena, Germany.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Dura Biotech is a medical device startup company that develops heart valve products for the cardiovascular marketplace.

coramaze technologies GmbH, a medical device company, develops a minimally invasive valve repair system for people with heart diseases. The company develops mitramaze valve repair system, a catheter-based valve that can be implanted directly into the beating heart and targets inoperable and asymptomatic patients. coramaze technologies GmbH was founded in 2013 and is based in Essen, Germany.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Hangzhou Valgen Medtech Co., Ltd. is a company headquartered in Hangzhou, China, that develops and manufactures novel mitral valve repair systems. The firm was founded in 2015. Ting Chao Zhang is currently the CEO of the company.